Tiotropium (as bromide monohydrate) 18mcg/cap; dry pwd in caps for oral inhalation; with inhaler device. Spiriva Handihaler consists of Spiriva capsules and the Handihaler device. Spiriva capsules ...
Tiotropium (as bromide monohydrate) 1.25mcg, 2.5mcg; per actuation; inh spray; contains benzalkonium chloride. Spiriva Respimat Inhalation Spray is supplied in a carton containing one Spiriva Respimat ...
If you have breathing problems caused by certain lung conditions, your doctor may prescribe Spiriva for you. Spiriva is a prescription drug that comes in two forms. The form your doctor prescribes ...
SPIRIVA RESPIMAT Inhalation Spray is now available by prescription through retail pharmacies across the United States for the long-term, once-daily maintenance treatment of bronchospasm associated ...
Spiriva (tiotropium) is a prescription drug used to treat specific breathing conditions. Spiriva’s cost may depend on factors such as your dosage, whether you have health insurance, and the pharmacy ...
Major League Baseball’s annual All-Star Game last night featured new DTC spots for Spiriva HandiHaler, an inhaler indicated for chronic bronchitis and emphysema. The television spots were created by ...
INGELHEIM AM RHEIN, Germany & NEW YORK, N.Y., USA--(BUSINESS WIRE)--Results of the one-year Prevention Of Exacerbations with Tiotropium in COPD (POET-COPD ®) study, published today by the New England ...
Long-term, Head-to-Head Study Showed SPIRIVA HandiHaler (tiotropium bromide inhalation powder) Significantly Prolonged Time to First Moderate or Severe COPD Exacerbation versus Salmeterol HFA-MDI The ...
ORLANDO, Fla., May 24 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. and Pfizer Inc announced today that Spiriva(R) HandiHaler(R) (tiotropium bromide inhalation powder), a new option for ...
DUBLIN--(BUSINESS WIRE)--The "Spiriva" report has been added to ResearchAndMarkets.com's offering. Spiriva (tiotropium; Boehringer Ingelheim) is a long-acting muscarinic antagonist (LAMA) approved for ...
RIDGEFIELD, Conn. & NEW YORK--(BUSINESS WIRE)--The U.S. Food and Drug Administration (FDA) Pulmonary-Allergy Drugs Advisory Committee voted 11 to 1 that clinical data included in a supplemental new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results